Drug Profile


Alternative Names: VUFB 15754

Latest Information Update: 28 Sep 2001

Price : $50

At a glance

  • Originator Nonindustrial source
  • Developer IVAX Pharmaceuticals s.r.o.; Nonindustrial source
  • Class Antiulcers; Nootropics
  • Mechanism of Action Dopamine receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Alzheimer's disease; Duodenal ulcer; Parkinson's disease; Skin disorders

Most Recent Events

  • 28 Sep 2001 No-Development-Reported for Skin disorders in Czech Republic (Unknown route)
  • 28 Sep 2001 No-Development-Reported for Duodenal ulcer in Czech Republic (Unknown route)
  • 28 Sep 2001 No-Development-Reported for Alzheimer's disease in Czech Republic (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top